Elucidation of molecular expression in patients with idiopathic interstitial pneumonia using multidisciplinary proteomic analysis and its clinical application
Project/Area Number |
18K15947
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 53030:Respiratory medicine-related
|
Research Institution | Hamamatsu University School of Medicine |
Principal Investigator |
Hozumi Hironao 浜松医科大学, 医学部附属病院, 助教 (40771457)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | 特発性肺線維症 / プロテオミクス / バイオマーカー / 特発性間質性肺炎 / グライコプロテオミクス |
Outline of Final Research Achievements |
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with a poor prognosis characterized by irreversible fibrosis of the lung. However, the clinical course of patients with IPF is variable and unpredictable. A biomarker that can predict disease progression and poor prognosis would help to determine the treatment strategy at an appropriate time. In this study, we explored biomarkers associated with disease progression using comprehensive proteomic analyses of specimens from patients with IPF, and found several promising molecules among a number of candidates. In particular, cold-inducible RNA-binding protein (CIRBP) was highly expressed in the blood and lung fibrotic tissues of patients with IPF and was validated in two independent IPF cohorts to be a promising biomarker for predicting disease progression and mortality.
|
Academic Significance and Societal Importance of the Research Achievements |
IPF患者の臨床経過は多様であり、進行が早く予後不良な患者もいれば、無治療でも進行に乏しい患者もいる。抗線維化薬や肺移植は重要な治療選択肢であるが、有害事象・合併症や生活の質の低下、医療コスト等が問題となるため、治療介入決定には重症度や疾患進行速度を考慮する必要がある。血清CIRBPの測定は、ハイリスクなIPF患者の早期同定によって治療方針の早期決定に役立ち、予後の改善に貢献できるものと考えられる。またIPF肺の線維化組織におけるCIRBPの高発現は、CIRBPとIPFの病態との関連性が示唆され、CIRBPが将来的な治療標的となる可能性も考えられた。
|
Report
(4 results)
Research Products
(63 results)
-
[Journal Article] Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis2021
Author(s)
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T.
-
Journal Title
Chest .
Volume: S0012-3692(21)
Issue: 6
Pages: 00259-2
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung2021
Author(s)
Sakurai S, Furuhashi K, Horiguchi R, Nihashi F, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T,
-
Journal Title
Allergology International
Volume: -
Issue: 3
Pages: 351-359
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival2021
Author(s)
Aoshima Y, Karayama M, Horiike Y, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T.
-
Journal Title
BMC Pulm Med.
Volume: 21(1)
Issue: 1
Pages: 63-63
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease2021
Author(s)
Koda K, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.
-
Journal Title
Sci Rep .
Volume: 11(1)
Issue: 1
Pages: 1682-1682
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study2020
Author(s)
Suzuki Y, Karayama M, Uto T, Fujii M, Matsui T, Asada K, Kusagaya H, Kato M, Matsuda H, Matsuura S, Toyoshima M, Mori K, Ito Y, Koyauchi T, Yasui H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.
-
Journal Title
Journal of Thoracic Oncology
Volume: S1556
Issue: 8
Pages: 1317-1327
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View2020
Author(s)
Akiyama N, Fujisawa T, Morita T, Mori K, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
-
Journal Title
J Pain Symptom Manage.
Volume: 60(5)
Issue: 5
Pages: 933-940
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis2020
Author(s)
Enomoto N, Naoi H, Aono Y, Katsumata M, Horiike Y, Yasui H, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.
-
Journal Title
Ther Adv Respir Dis.
Volume: 14
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Pneumothorax in connective tissue disease-associated interstitial lung disease.2020
Author(s)
Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Suda T.
-
Journal Title
PLoS One.
Volume: 15(7)
Issue: 7
Pages: e0235624-e0235624
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer2020
Author(s)
Inoue Y, Yoshimura K, Nishimoto K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Sugimura H, Suda T.
-
Journal Title
JAMA Netw Open.
Volume: 3(9)
Issue: 9
Pages: e2011818-e2011818
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.2020
Author(s)
Kamiya Y, Fujisawa T, Katsumata M, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Setou M, Ito M, Suzuki T, Ikegami K, Suda T.
-
Journal Title
Respir Res.
Volume: 21
Issue: 1
Pages: 282-282
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer.2020
Author(s)
Karayama M, Yoshizawa N, Sugiyama M, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Goshima S, Suda T, Takehara Y.
-
Journal Title
Lung Cancer
Volume: 143
Pages: 47-54
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.2020
Author(s)
Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T.
-
Journal Title
Therapeutic Advances in Respiratory Disease
Volume: 14
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.2019
Author(s)
Akiyama N, Hozumi H, Isayama T, Okada J, Sugiura K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.
-
Journal Title
Respirology
Volume: 0
Issue: 7
Pages: 0-0
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.2019
Author(s)
Tsuchiya K, Suzuki Y, Yoshimura K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T.
-
Journal Title
Scientific Reports
Volume: 9
Issue: 1
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.2019
Author(s)
Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Sumikawa H, Johkoh T, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
-
Journal Title
Respiratory Medicine
Volume: 159
Pages: 105811-105811
DOI
Related Report
Peer Reviewed
-
[Journal Article] Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.2019
Author(s)
Suzuki Y, Inui N, Karayama M, Imokawa S, Yamada T, Yokomura K, Asada K, Kusagaya H, Kaida Y, Matsuda H, Koshimizu N, Toyoshima M, Masuda M, Hayakawa H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Suda T.
-
Journal Title
International Journal of Chronic Obstructive Pulmonary Disease
Volume: 14
Pages: 1867-1877
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.2019
Author(s)
Furuhashi K, Fujisawa T, Hashimoto D, Kamiya Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T.
-
Journal Title
Journal of Asthma and Allergy
Volume: 12
Pages: 253-261
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.2019
Author(s)
Kono M, Nakamura Y, Enomoto N, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Kobayashi T, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Inui N, Suda T, Nakamura H.
-
Journal Title
Respir Investig.
Volume: 57
Issue: 6
Pages: 552-560
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.2019
Author(s)
Akahori D, Suzuki Y, Yokomura K, Shirai M, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Hayakawa H, Suda T.
-
Journal Title
Journal of Infection
Volume: 79
Issue: 4
Pages: 341-348
DOI
Related Report
Peer Reviewed
-
[Journal Article] Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.2019
Author(s)
Enomoto N, Oyama Y, Yasui H, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.
-
Journal Title
Scientific Reports
Volume: 9
Issue: 1
Pages: 10484-10484
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.2019
Author(s)
Karayama M, Inui N, Yasui H, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.
-
Journal Title
International Journal of Chronic Obstructive Pulmonary Disease
Volume: 14
Pages: 1333-1342
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias2019
Author(s)
Katsumata M, Hozumi H, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.
-
Journal Title
Respir Med
Volume: 154
Pages: 102-108
DOI
Related Report
Peer Reviewed
-
[Journal Article] Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD2019
Author(s)
Horiike Yasuoki, Suzuki Yuzo, Fujisawa Tomoyuki, Yasui Hideki, Karayama, Masato, Hozumi Hironao, Furuhashi Kazuki, Enomoto Noriyuki, Nakamura Yutaro, Inui Naoki, Ogawa Noriyoshi, Suda Takafumi
-
Journal Title
Rheumatology
Volume: 印刷中
Issue: 12
Pages: 2143-2152
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.2019
Author(s)
Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T.
-
Journal Title
Cancer Chemotherapy and Pharmacology
Volume: 84
Issue: 1
Pages: 147-153
DOI
Related Report
Peer Reviewed
-
[Journal Article] Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.2019
Author(s)
Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Hashisako M, Tanaka T, Terasaki Y, Kunugi S, Kitani M, Okuda R, Horiike Y, Enomoto Y, Yasui H, Hozumi H, Suzuki Y, Nakamura Y, Fukuoka J, Johkoh T, Kondoh Y, Ogura T,,, Suda T.
-
Journal Title
Eur Respir J.
Volume: 3
Issue: 5
Pages: 1802243-1802243
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
[Journal Article] Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion2018
Author(s)
Saito G, Kono M, Tsutsumi A, Koyanagi Y, Miyashita K, Kobayashi T, Hozumi H, Miki Y, Arai Y, Otsuki Y, Hashimoto D, Fujisawa T, Nakamura T, Suda T, Nakamura H.
-
Journal Title
Internal Medicine
Volume: 57
Issue: 15
Pages: 2227-2232
DOI
NAID
ISSN
0918-2918, 1349-7235
Year and Date
2018-08-01
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.2018
Author(s)
Yoshimura K, Kono M, Enomoto Y, Nishimoto K, Oyama Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Colby TV, Sugimura H, Suda T.
-
Journal Title
Respiratory Medicine
Volume: 137
Pages: 167-175
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis.2018
Author(s)
Kato S, Inui N, Hozumi H, Inoue Y, Yasui H, Karayama M, Kono M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.
-
Journal Title
Respiratory Medicine
Volume: 印刷中
Pages: S20-S23
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Presentation] 14-3-3γ Protein: A Novel Serum Biomarker for Predicting Prognosis in Idiopathic Pulmonary Fibrosis.2020
Author(s)
Hozumi H, Isayama T, Okada J, Sugiura K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Hayakawa H, Suda T
Organizer
American Thoracic Society 2020 International Conference
Related Report
Int'l Joint Research
-
[Presentation] 特発性肺線維症における14-3-3γ蛋白の臨床的有用性2020
Author(s)
穗積宏尚, 安井秀樹, 鈴木勇三, 河野雅人, 柄山正人, 古橋一樹, 榎本紀之, 藤澤朋幸, 乾直輝, 中村祐太郎, 須田隆文
Organizer
第60回日本呼吸器学会学術講演会
Related Report
-
[Presentation] Clinical Utility of Serum S100 Calcium Binding Protein A4 in Idiopathic Pulmonary Fibrosis2019
Author(s)
N. Akiyama, H. Hozumi, H. Yasui, M. Kono, Y. Suzuki, M. Karayama, K. Furuhashi, N. Enomoto, T. Fujisawa, N. Inui, Y. Nakamura, T. Suda
Organizer
ATS Conference 2019 - American Thoracic Society
Related Report
Int'l Joint Research
-